Fecal DNA Testing in Screening for Colorectal Cancer in Average Risk Adults - Research Review - Final | AHRQ Effective Health Care Program

Fecal DNA Testing in Screening for Colorectal Cancer in Average Risk Adults - Research Review - Final | AHRQ Effective Health Care Program

Insufficient Evidence to Support Fecal DNA Testing in Colorectal Cancer Screening in Average Risk Adults

Insufficient evidence currently exists to support the use of fecal DNA tests to accurately screen adults at average risk and who show no symptoms for colorectal cancer, a new review from AHRQ's Effective Health Care Program finds. Colorectal cancer is the third most common cancer in both men and women, and screening rates of the cancer are poor. The review, Fecal DNA Testing in Screening for Colorectal Cancer in Average Risk Adults, calls for further research about the effectiveness of fecal DNA testing, especially given recent scientific advances in this area. Further research on the accuracy of, as well as acceptability and adherence to, fecal DNA testing compared to other stool-based screening tests is needed

Research Review - Final – Feb. 29, 2012

Fecal DNA Testing in Screening for Colorectal Cancer in Average Risk Adults

Formats

• View PDF 1.5 MB